| P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
| P17 | country | Israel | Q801 |
| P582 | end time | 2008-01-01 | |
| P4135 | maximum age | 4 | |
| P1132 | number of participants | 2799 | |
| P6153 | research site | Tel Aviv University | Q319239 |
| | Long Island Jewish Medical Center | Q6672700 |
| P8005 | research subject recruitment status | completed | Q76651189 |
| P859 | sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
| P580 | start time | 2003-01-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase 3 Study (Safety, Immunogenicity and Efficacy) of Improved Shigella Conjugate Vaccines in 1-4 Year Olds in Israel | |